Protocol for the Lactoferrin Infant Feeding Trial (LIFT): A randomised trial of adding lactoferrin to the feeds of very-low birthweight babies prior to hospital discharge

BMJ Open

Volumn 8, Issue 10, 2018, Pages

  Martin, Andrew ^a   Ghadge, Alpana ^a   Manzoni, Paolo ^b   Lui, Kei ^c   Brown, Rebecca ^a   Tarnow Mordi, William ^a   Lu, Kei ^d   Simes, John ^e   Hague, Wendy ^e   Osborn, David ^e   Deshpande, Girish ^e   Kochar, Anu ^e   Lewis, Tony ^e   Watkins, Andrew ^e   Pritchard, Margo ^e   Schofield, Deborah ^e   Mohamed, Abdel Latif ^e   Soll, Roger ^e   Darlow, Brian ^e   Isaacs, David ^e   Wilkinson, Dominic ^e   Wood, Alicia ^e   McKenzie, Anne ^e   Despande, Girish ^e   Verry, Hannah ^e   Wright, Ian ^e   Askie, Lisa ^e   Cruz, Melinda ^e   Berry, Nina ^e   McGuire, William ^e   Broom, Marg ^e   Osoborn, David ^e   Reid, Shelley ^e   Sinn, John ^e   Kwan, Peggy ^e   Tracy, Mark ^e   Hua, Carol ^e   Travadi, Javeed ^e   Black, Ros ^e   Tobiansky, Rodney ^e   Darcy, DIanne ^e   Tai, Suk Ngor Honvi ^e   Michalowski, Jo ^e   Deshpande, Girsh ^e   Bhaskaracharya, Archana ^e   Yeomans, Emma ^e   Elsayed, Kristy ^e   Collins, Clare ^e   Noble, Elizabeth ^e   Koorts, Pieter ^e   Lack, Gill ^e   McKeown, Lisa ^e   Liley, Helen ^e   Nie, Wenjun ^e   Morris, Scott ^e   Cornthwaite, Kathy ^e   Goodchild, Louise ^e   Austin, Nicola ^e   Graham, Trisha ^e   Patel, Harshad ^e   Sanchez, Dorothy ^e   McKinlay, Chris ^e   Modi, Neena ^e   Marschner, Ian ^e   Stenson, Ben ^e   Espinoza, David ^e   more..

^a UNIVERSITY OF SYDNEY   (Australia)

^b S ANNA HOSPITAL   (Italy)

^c ROYAL HOSPITAL FOR WOMEN   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e NONE

Author keywords

Enterocolitis; infant; lactoferrin; necrotizing; premature; sepsis

Indexed keywords

LACTOFERRIN;

BABY FOOD; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HOSPITAL MORTALITY; HUMAN; INFANT; INFANT MORTALITY; MALE; NEONATAL INTENSIVE CARE UNIT; NEWBORN; RANDOMIZED CONTROLLED TRIAL; VERY LOW BIRTH WEIGHT;

CLINICAL PROTOCOLS; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; INFANT FOOD; INFANT MORTALITY; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LACTOFERRIN; MALE;

EID: 85054424083     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2018-023044     Document Type: Article

References (50)

1. Blencowe H, Cousens S, Oestergaard MZ, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet 2012;379:2162-72.
2. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2012. Natl Vital Stat Rep 2013;62:1-20.
3. Chow SSW, Le Marsney R, Creighton P, et al. Report of the Australian and New Zealand Neonatal Network 2015. Sydney: ANZNN, 2017.
4. Australian Institute of Health and Welfare. Australia's mothers and babies 2015 - in brief. Perinatal statistics series no. 33 Cat no. PER 91. Canberra: Australian Institute of Health and Welfare, 2017.
5. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261-9.
6. Moore T, Hennessy EM, Myles J, et al. Neurological and developmental outcome in extremely preterm children born in England in 1995 and 2006: the EPICure studies. BMJ 2012;345:e7961.
7. Botting N, Powls A, Cooke RW, et al. Attention deficit hyperactivity disorders and other psychiatric outcomes in very low birthweight children at 12 years. J Child Psychol Psychiatry 1997;38:931-41.
8. Svedenkrans J, Henckel E, Kowalski J, et al. Long-term impact of preterm birth on exercise capacity in healthy young men: a national population-based cohort study. PLoS One 2013;8:e80869.
9. Lönnerdal B. Nutritional roles of lactoferrin. Curr Opin Clin Nutr Metab Care 2009;12:293-7.
10. Scott PH. Plasma lactoferrin levels in newborn preterm infants: effect of infection. Ann Clin Biochem 1989;26(Pt 5):412-5.
11. Decembrino L, DeAmici M, De Silvestri A, et al. Plasma lactoferrin levels in newborn preterm infants with sepsis. J Matern Fetal Neonatal Med 2017;30:2890-3.
12. Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. Biochimie 2009;91:30-4.
13. Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005;62:2576-87.
14. Leitch EC, Willcox MD. Lactoferrin increases the susceptibility of S. epidermidis biofilms to lysozyme and vancomycin. Curr Eye Res 1999;19:12-19.
15. Groot F, Geijtenbeek TB, Sanders RW, et al. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN - gp120 interaction. J Virol 2005;79:3009-15.
16. Lupetti A, Paulusma-Annema A, Welling MM, et al. Candidacidal activities of human lactoferrin peptides derived from the N terminus. Antimicrob Agents Chemother 2000;44:3257-63.
17. Rahman MM, Kim WS, Ito T, et al. Growth promotion and cell binding ability of bovine lactoferrin to Bifidobacterium longum. Anaerobe 2009;15:133-7.
18. Kaufman DA. Lactoferrin supplementation to prevent nosocomial infections in preterm infants. JAMA 2009;302:1467-8.
19. Vorland LH, Ulvatne H, Rekdal O, et al. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 1999;31:467-73.
20. Vorland LH, Ulvatne H, Andersen J, et al. Antibacterial effects of lactoferricin B. Scand J Infect Dis 1999;31:179-84.
21. Manzoni P, García Sánchez R, Meyer M, et al. Exposure to gastric acid inhibitors increases the risk of infection in preterm very low birth weight infants but concomitant administration of lactoferrin counteracts this effect. J Pediatr 2018;193:62-7.
22. Embleton NE, Pang N, Cooke RJ. Postnatal malnutrition and growth retardation: an inevitable consequence of current recommendations in preterm infants? Pediatrics 2001;107:270-3.
23. Venkatesh M, Abrams S. Can lactoferrin prevent neonatal sepsis and necrotizing enterocolitis? Expert Rev Anti Infect Ther 2009;7:515-25.
24. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2014;(4):CD005496.
25. Raghuveer TS, McGuire EM, Martin SM, et al. Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products. Pediatr Res 2002;52:964-72.
26. Office of Food Additive Safety. GRAS notice GRN 669. Food and Drug Administration. Generally Recognized As Safe (GRAS) Notice: The Use ofBovine Milk-derived Lactoferrin In Term Milk-based Infant Formulas and Toddler Formulas. https://www. fda. gov/downloads/food/ingr edie ntsp acka ging labeling/gras/noticeinventory/ucm592102. pdf (accessed 5 Mar 2018).
27. Cheng JB, Wang JQ, Bu DP, Dp B, et al. Factors affecting the lactoferrin concentration in bovine milk. J Dairy Sci 2008;91:970-6.
28. Yamauchi K, Toida T, Nishimura S, et al. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 2000;38:503-12.
29. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birthweight neonates: a randomized trial. JAMA 2009;302:1421-8.
30. Pammi M, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011;(10):CD007137.
31. Pammi M, Suresh G. Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2017;(6):CD007137.
32. ANZNN. Australian and New Zealand Neonatal Network. ANZNN 2009 Data Dictionary. Sydney, Australia. Sydney: UNSW, 2008.
33. ANZNN. Australian and New Zealand Neonatal Network. ANZNN 2009/2010 Follow-up Data Dictionary. Sydney, Australia.: UNSW, 2013.
34. Tarnow-Mordi W, Morris J, Kirby A, et al. Delayed versus Immediate Cord Clamping in Preterm Infants. N Engl J Med 2017;377:2445-55.
35. Askie LM, Henderson-Smart DJ, Irwig L, et al. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003;349:959-67.
36. Askie LM, Brocklehurst P, Darlow BA, et al. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr 2011;11:6.
37. Morley CJ, Davis PG, Doyle LW, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700-8.
38. Jacobs SE, Morley CJ, Inder TE, et al. Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med 2011;165:692-700.
39. Schmidt B. Methylxanthine therapy for apnea of prematurity: evaluation of treatment benefits and risks at age 5 years in the international Caffeine for Apnea of Prematurity (CAP) trial. Biol Neonate 2005;88:208-13.
40. Saigal S, Stoskopf BL, Feeny D, et al. Differences in preferences for neonatal outcomes among health care professionals, parents, and adolescents. JAMA 1999;281:1991-7.
41. Cordoba G, Schwartz L, Woloshin S, et al. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 2010;341:c3920.
42. Ferreira-González I, Permanyer-Miralda G, Busse JW, et al. Methodologic discussions for using and interpreting composite endpoints are limited, but still identify major concerns. J Clin Epidemiol 2007;60:651-7. discussion 658-662.
43. Schmidt B, Asztalos EV, Roberts RS, et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 2003;289:1124-9.
44. Bassler D, Stoll BJ, Schmidt B, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009;123:313-8.
45. Schulzke SM, Deshpande GC, Patole SK. Neurodevelopmental outcomes of very low-birth-weight infants with necrotizing enterocolitis: a systematic review of observational studies. Arch Pediatr Adolesc Med 2007;161:583-90.
46. Actor JK, Hwang SA, Kruzel ML. Lactoferrin as a natural immune modulator. Curr Pharm Des 2009;15:1956-73.
47. Berlutti F, Schippa S, Morea C, et al. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive Escherichia coli strains. Biochem Cell Biol 2006;84:351-7.
48. Kapoor K, Basu S, Das BK, et al. Lipid peroxidation and antioxidants in neonatal septicemia. J Trop Pediatr 2006;52:372-5.
49. Silveira RC, Procianoy RS, Dill JC, et al. Periventricular leukomalacia in very low birth weight preterm neonates with high risk for neonatal sepsis. J Pediatr 2008;84:211-6.
50. Deshpande GC, Rao SC, Keil AD, et al. Evidence-based guidelines for use of probiotics in preterm neonates. BMC Med 2011;9:92.